Quantitative real-time PCR and Western blot results indicated that the LHFPL3-AS1 knockdown led a significant decrease of Bcl-2 expression in melanoma stem cells, but had no effect on VEGF expression (Fig. 3B, C). The gene discussed is BCL2; the disease is melanoma.